CAI Q2 2020 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M-28.3% YoY

Gross Profit

$47M61.9% margin

Operating Income

$33M43.6% margin

Net Income

-$626,000-0.8% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-27.9%

Cash Flow

Operating Cash Flow

$66M

Free Cash Flow

$60M

Stock-Based Comp.

-$73,000

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$2.1B

Stockholders' Equity

$687M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$106M	-28.3%
Gross Profit	$47M	$51M	-7.8%
Operating Income	$33M	$34M	-4.1%
Net Income	-$626,000	$9M	-106.7%